skip to the content

 

cobas® EGFR Mutation Test

Identifies mutations in exons 18, 19, 20 and 21 of the EGFR gene.

The cobas® EGFR Mutation Test offers broad mutation coverage of EGFR exons 18, 19, 20 and 21 to help select non-small cell lung cancer (NSCLC) patients for treatment with EGFR inhibitors.

Further information